Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. <a href="https://www.creative-biolabs.com/adc/one-stop-adc-development-service.htm" target="_blank">Antibody-drug conjugates</a> (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature.

Monoclonal antibody-based immunotherapies against cancer and other infectious diseases are highly advantageous comparing to conventional therapeutic approaches due to their high specificity and affinity towards well-defined targets. Antibody-drug conjugates (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature.

BIOTECH FUN

A Brief Introduction of Antibody Drug Conjugate

Welcome to my first podcast! I hope you enjoy listening to it!

About

A Brief Introduction of Antibody Drug Conjugate